IDH1 and astrocytoma (excluding glioblastoma): These findings suggest that, similar to IDH1-mutant astrocytoma, co-existing CNAs that activate retinoblastoma (RB) and PDGFR signaling pathway may critically drive tumor progression and xenograft formation in IDH2-mutant astrocytoma.